With the speculation re possible prices I figured that the screenshots below would be a good place to start...........
I would really like to know some details of what was in the updates that are referred to in todays ann..........."Botanix also held meetings with a range of potential partners, presenting updates on the Phase 2 acne and atopic dermatitis clinical studies and the Phase 1b psoriasis program"
But then there's this comparison to consider..........and after all BOT are 'GLOBAL leaders' in the CBD clinical trial space for Derma based development right now..............
Bot Chart, page-213
-
- There are more pages in this discussion • 227 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 34.0¢ | 31.5¢ | $1.478M | 4.506M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 107150 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 594669 | 9 |
View Market Depth
| Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
